BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bausch Health Says Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference

01/11/2022 | 07:14am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BAUSCH HEALTH COMPANIES INC. 2.92% 9.86 Delayed Quote.-65.30%
ON SEMICONDUCTOR CORPORATION 5.49% 59.33 Delayed Quote.-17.20%
All news about BAUSCH HEALTH COMPANIES INC.
07:21aPiper Sandler Adjusts Bausch Health's Price Target to $7 From $27, Maintains Neutral Ra..
MT
05/24TRANSCRIPT : Bausch Health Companies Inc. Presents at Barclays Leveraged Finance Conferenc..
CI
05/24TRANSCRIPT : Bausch Health Companies Inc. Presents at Barclays High Yield Bond & Syndicate..
CI
05/24Bausch + Lomb Receives Health Canada Approval of Lumify Redness Reliever Eye Drops
MT
05/24BAUSCH + LOMB BRIEF : Receives Health Canada Approval of LUMIFY Redness Reliever Eye Drops
MT
05/24Bausch + Lomb Eye-Drop Product Gets Health Canada Approval
DJ
05/19Salix Pharmaceuticals To Share New Data At Digestive Disease Week 2022
AQ
05/18Bausch Health Says Salix Pharmaceuticals To Share New Data
MT
05/16Moody's Cuts Bausch Health's Senior Secured Ratings
MT
05/12TRANSCRIPT : Bausch Health Companies Inc. Presents at Goldman Sachs 7th Annual Leveraged F..
CI
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES INC.
More recommendations
Financials (USD)
Sales 2022 8 329 M - -
Net income 2022 -34,3 M - -
Net Debt 2022 19 398 M - -
P/E ratio 2022 -104x
Yield 2022 -
Capitalization 3 564 M 3 564 M -
EV / Sales 2022 2,76x
EV / Sales 2023 2,51x
Nbr of Employees 19 600
Free-Float 95,8%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | BHC | CA0717341071 | MarketScreener
Technical analysis trends BAUSCH HEALTH COMPANIES INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 9,86 $
Average target price 28,80 $
Spread / Average Target 192%
EPS Revisions
Managers and Directors
Robert N. Power Chief Executive Officer & Director
Thomas J. Appio President & Co-Head-Bausch Lomb International
Sam A. Eldessouky CFO, Chief Accounting Officer, SVP & Controller
Joseph C. Papa Chairman
Tage Ramakrishna Chief Medical Officer, President-R&D
Sector and Competitors
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC.-65.30%3 463
JOHNSON & JOHNSON5.00%472 652
PFIZER, INC.-9.04%301 361
ROCHE HOLDING AG-12.16%281 908
ELI LILLY AND COMPANY11.15%276 358
ABBVIE INC.12.23%268 530